Sandy Spring Bank Has $17.51 Million Holdings in Danaher Co. (NYSE:DHR)

Sandy Spring Bank lessened its stake in Danaher Co. (NYSE:DHR - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 76,277 shares of the conglomerate's stock after selling 1,804 shares during the quarter. Danaher makes up approximately 0.7% of Sandy Spring Bank's holdings, making the stock its 28th biggest holding. Sandy Spring Bank's holdings in Danaher were worth $17,509,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Gilbert & Cook Inc. lifted its stake in Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate's stock valued at $401,000 after buying an additional 42 shares during the period. Grimes & Company Inc. raised its position in shares of Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate's stock valued at $1,696,000 after acquiring an additional 43 shares during the period. Dakota Community Bank & Trust NA boosted its stake in Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate's stock worth $73,000 after acquiring an additional 45 shares during the last quarter. Howard Capital Management Group LLC grew its holdings in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock valued at $342,000 after purchasing an additional 48 shares during the period. Finally, Spinnaker Trust increased its stake in Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate's stock valued at $988,000 after purchasing an additional 50 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Remove Ads

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company's stock.

Danaher Stock Performance

Shares of Danaher stock traded up $1.61 on Monday, hitting $212.97. The stock had a trading volume of 3,615,085 shares, compared to its average volume of 3,019,141. The stock has a market cap of $152.21 billion, a price-to-earnings ratio of 40.33, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The business's 50 day moving average is $217.46 and its two-hundred day moving average is $238.50. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business posted $2.09 EPS. Analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a boost from Danaher's previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.60%. Danaher's payout ratio is 24.24%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on DHR. Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 price target for the company. StockNews.com downgraded Danaher from a "buy" rating to a "hold" rating in a report on Saturday, December 14th. Guggenheim assumed coverage on Danaher in a research report on Thursday, December 19th. They issued a "buy" rating and a $275.00 price objective for the company. Royal Bank of Canada restated an "outperform" rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Finally, Jefferies Financial Group cut their price target on Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a report on Wednesday, January 29th. Five investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $278.24.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.